Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson 2017. MSD 96-well human cytokine assay. protocols.io https://dx.doi.org/10.17504/protocols.io.hwzb7f6Copy Citation Copied
URL: https://dx.doi.org/DOI:10.17504/protocols.io.hwzb7f6
Authors: Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson
Summary: This protocol describes MesoScale Discovery (MSD) assays for measurement of proinflammatory cytokines in supernatants collected from T cell dependent cytotoxicity (TDCC) cultures after BiTE® treatment.
Associated Publications: Ross SL, Sherman M, McElroy PL, Lofgren JA, Moody G, Baeuerle PA, Coxon A, Arvedson T, Bispecific T cell engager (BiTE) antibody constructs can mediate bystander tumor cell killing. PLoS ONE 12(8). doi: 10.1371/journal.pone.0183390
Affiliations: Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc.
External URL: https://doi.org/10.1371/journal.pone.0183390
Version: 1
Publication Date: 2017
Expand AllComing soon.
Source: